Dr Snape's principal areas of research relate to vaccines against meningococcal, pneumococcal, influenza and ebola disease, and prevention of disease through maternal immunisation.
Dr Snape was acknowledged as an NIHR Clinical Research Network ‘Leading Commercial Principal Investigator’ in 2015 by Dame Sally Davis, Chief Medical Office, and has published over 70 manuscripts relating to immunisation. He is also a member of the Meningitis Research Foundation's Medical Advisory Group.
- Childhood vaccines
- Vaccines for ebola
Dr Snape has experience of print and broadcast media.